Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 1 medicine
AEMPS · 1 medicine
EMA · 1 medicine
HALMED · 1 medicine
AIFA · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 1 medicine
FDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
7 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Klisyri | United States | 1% | ointment | Marketed | Almirall |
| Klisyri | European Union | Authorised | Almirall, S.A. | ||
| Klisyri 10 MG/G Pomada | Spain | 2,5 mg | pomada | Marketed | Almirall S.A. |
| Klisyri | Italy | Unguento | Authorised | Almirall S.A. | |
| Klisyri 10 mg/g, zalf | Netherlands | Zalf | Authorised | Grupo Farmacéutico Almirall S.A. | |
| Onakta | Canada | 1 % / W/W | Ointment | Authorised | Avir Pharma INC. |
| Klisyri | Croatia | Authorised |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, EMA, FDA, HALMED and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
